ÂÜÀòÂÒÂ×

Marian Nakada, Ph.D. is a seasoned professional in the pharmaceutical and venture capital sectors, currently serving as a Board Observer at Arkuda Therapeutics since January 2024 and holding the position of Vice President of Venture Investments at Johnson & Johnson since January 2013. With extensive involvement in venture capital, Nakada also acts as an Advisor for the Convergence Forum and is a Board Member and Chair for Ribon Therapeutics and Navitor Pharmaceuticals, respectively. Other notable roles include membership in Global Women in VC and past Board Member positions with the New England Venture Capital Association and Redona Therapeutics. Nakada's educational background includes a Bachelor of Arts in Biology from Harvard University and a Ph.D. in Pharmacology from the University of Pennsylvania.